Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | 2.11% | 488.00 | 1.0% | $769.29m | |
| DHR | Danaher Corp. | 0.78% | 239.01 | 0.7% | $656.80m | |
| MDT | Medtronic Plc | 0.55% | 124.57 | 0.6% | $617.90m | |
| ABT | Abbott Laboratories | 0.69% | 122.28 | 0.8% | $605.46m | |
| ALGN | Align Technology, Inc. | 0.00% | 594.93 | 6.3% | $358.42m | |
| ISRG | Intuitive Surgical, Inc. | 0.00% | 785.83 | 2.3% | $347.03m | |
| SYK | Stryker Corp. | -0.02% | 252.25 | 1.3% | $298.93m | |
| NVCR | NovoCure Ltd. | 0.00% | 186.00 | 6.8% | $279.45m | |
| DXCM | DexCom, Inc. | 0.00% | 391.10 | 7.8% | $277.48m | |
| BDX | Becton, Dickinson & Co. | 0.12% | 250.11 | 1.0% | $275.09m | |
| BSX | Boston Scientific Corp. | -0.03% | 39.66 | 1.0% | $244.85m | |
| IDXX | IDEXX Laboratories, Inc. | 0.16% | 515.00 | 3.7% | $224.27m | |
| BAX | Baxter International, Inc. | 0.07% | 84.70 | 1.8% | $220.94m | |
| EW | Edwards Lifesciences Corp. | -0.04% | 86.22 | 0.4% | $220.84m | |
| A | Agilent Technologies, Inc. | -0.08% | 131.87 | 1.6% | $187.81m |
Company Profile
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. The ArgusCYTE Breast Health Test offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.